Back

Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar

2022-02-08 epidemiology Title + abstract only
View on medRxiv
Show abstract

BACKGROUNDQatar has been experiencing a large SARS-CoV-2 Omicron (B.1.1.529) wave that started on December 19, 2021. We assessed duration of protection of BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines after second dose and after third/booster dose against symptomatic Omicron infection and against COVID-19 hospitalization and death, between December 23, 2021 and February 2, 2022. METHODSVaccine effectiveness was estimated using the test-negative, case-control study design,...

Predicted journal destinations

1
New England Journal of Medicine
49 training papers
#1 22.8%
2
Nature Communications
483 training papers
Top 7% 12.1%
3
Clinical Infectious Diseases
219 training papers
Top 2% 9.2%
4
Vaccine
140 training papers
Top 2% 6.6%
5
The Journal of Infectious Diseases
137 training papers
Top 2% 5.1%
6
BMC Medicine
155 training papers
Top 6% 3.7%
7
The Lancet Infectious Diseases
57 training papers
Top 1% 2.0%
8
Vaccines
131 training papers
Top 4% 2.0%
9
PLOS ONE
1737 training papers
Top 92% 2.0%
10
Nature Medicine
88 training papers
Top 2% 2.0%
11
Open Forum Infectious Diseases
124 training papers
Top 6% 2.0%
12
Eurosurveillance
77 training papers
Top 5% 1.6%
13
Scientific Reports
701 training papers
Top 85% 1.6%
14
International Journal of Infectious Diseases
115 training papers
Top 12% 1.6%
15
eLife
262 training papers
Top 28% 1.6%
16
PLOS Medicine
95 training papers
Top 10% 1.4%
17
American Journal of Epidemiology
54 training papers
Top 6% 1.2%
18
Science
46 training papers
Top 4% 1.2%
19
JAMA Network Open
125 training papers
Top 23% 1.0%
20
International Journal of Epidemiology
65 training papers
Top 10% 1.0%
21
Journal of Infection
64 training papers
Top 8% 1.0%
22
BMC Infectious Diseases
110 training papers
Top 26% 0.7%
23
Nature
58 training papers
Top 10% 0.7%
24
Influenza and Other Respiratory Viruses
36 training papers
Top 2% 0.7%
25
Emerging Infectious Diseases
84 training papers
Top 16% 0.7%
26
Epidemiology and Infection
80 training papers
Top 14% 0.7%
27
eClinicalMedicine
55 training papers
Top 5% 0.7%